VOGONIA M 0.3/500 Tablets – Empowered Control for Type 2 Diabetes
VOGONIA M 0.3/500 Tablets combine Voglibose 0.3 mg and Metformin 500 mg, offering a synergistic approach to manage Type 2 diabetes with enhanced glycemic control.
Key Benefits of Voglibose 0.3 mg and Metformin 500 mg Tablets – VOGONIA M 0.3/500 Tablets:
✅ Postprandial Glucose Control: Voglibose slows carbohydrate absorption, reducing sugar spikes after meals.
✅ Improved Insulin Sensitivity: Metformin lowers hepatic glucose production and enhances peripheral glucose uptake.
✅ Dual Action Formula: Comprehensive blood sugar management with a single tablet.
✅ Weight Neutral: Does not promote weight gain, ensuring better overall health.
✅ Well-Tolerated: Advanced formulation minimizes gastrointestinal side effects.
Indications:
✅ Type 2 Diabetes Mellitus
✅ Postprandial Hyperglycemia
✅ As Add-On Therapy to Lifestyle Modifications